NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
49 hedge funds and large institutions have $51.5M invested in NeuBase Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 12 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
49
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$7.73M | |
| 2 | +$4.52M | |
| 3 | +$3.48M | |
| 4 |
GC
Greenlight Capital
New York
|
+$3.2M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.18M |
Top Sellers
| 1 | -$2.64M | |
| 2 | -$449K | |
| 3 | -$158K | |
| 4 |
Jane Street
New York
|
-$121K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$87K |